Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University, Seoul, Korea.
J Clin Periodontol. 2010 Apr;37(4):382-9. doi: 10.1111/j.1600-051X.2010.01544.x.
Recombinant human growth/differentiation factor-5 (rhGDF-5) is being evaluated as a candidate therapy in support of periodontal regeneration. The objective of this study was to evaluate periodontal wound healing/regeneration following the application of rhGDF-5 on a particulate beta-tricalcium phosphate (beta-TCP) carrier using an established defect model.
Bilateral 4 x 5 mm (width x depth), one-wall, critical-size, intrabony periodontal defects were surgically created at the mandibular second and fourth pre-molar teeth in 15 Beagle dogs. Unilateral defects in five animals received rhGDF-5/beta-TCP (Scil Technology GmbH); five animals received beta-TCP solo; and five animals served as sham-surgery controls. Contralateral sites received treatments reported elsewhere. The animals were sacrificed following an 8-week healing interval for histological examination.
Clinical healing was generally uneventful. Sites implanted with rhGDF-5/beta-TCP exhibited greater enhanced cementum and bone formation compared with beta-TCP and sham-surgery controls; cementum regeneration averaged (+/- SD) 3.83 +/- 0.73 versus 1.65 +/- 0.82 and 2.48 +/- 1.28 mm for the controls (p<0.05). Corresponding values for bone regeneration height averaged 3.26 +/- 0.30 versus 1.70 +/- 0.66 and 1.68 +/- 0.49 mm (p<0.05), and bone area 10.45 +/- 2.26 versus 6.31 +/- 2.41 and 3.00 +/- 1.97 mm(2) (p<0.05). Cementum regeneration included cellular/acellular cementum with or without a functionally oriented periodontal ligament. A non-specific connective tissue attachment was evident in the sham-surgery control. Controls exhibited mostly woven bone with primary osteons, whereas rhGDF-5/beta-TCP sites showed a noticeable extent of lamellar bone. Sites receiving rhGDF-5/beta-TCP or beta-TCP showed some residual beta-TCP granules apparently undergoing biodegradation without obvious differences between the sites. Sites receiving beta-TCP alone commonly showed residual beta-TCP granules sequestered in the connective tissue or fibrovascular marrow.
rhGDF-5/beta-TCP has a greater potential to support the regeneration of the periodontal attachment. Long-term studies are necessary to confirm the uneventful maturation of the regenerated tissues.
重组人生长/分化因子-5(rhGDF-5)被评估为一种候选治疗方法,以支持牙周再生。本研究的目的是使用已建立的缺损模型,评估 rhGDF-5 在颗粒状 β-磷酸三钙(β-TCP)载体上的应用对牙周伤口愈合/再生的影响。
在 15 只比格犬的下颌第二和第四前磨牙上,手术创建了双侧 4 x 5 毫米(宽 x 深)、一壁、临界尺寸、骨内牙周缺损。在五只动物的单侧缺损处给予 rhGDF-5/β-TCP(Scil Technology GmbH);五只动物接受β-TCP 单独治疗;五只动物作为假手术对照组。对侧部位接受了其他地方报道的治疗。在 8 周的愈合间隔后,动物被处死进行组织学检查。
临床愈合通常顺利。植入 rhGDF-5/β-TCP 的部位与β-TCP 和假手术对照组相比,表现出更强的增强牙骨质和骨形成;牙骨质再生平均(+/-SD)为 3.83 +/- 0.73 毫米,而对照组为 1.65 +/- 0.82 和 2.48 +/- 1.28 毫米(p<0.05)。相应的骨再生高度平均值为 3.26 +/- 0.30 毫米,而对照组为 1.70 +/- 0.66 和 1.68 +/- 0.49 毫米(p<0.05),骨面积为 10.45 +/- 2.26 毫米,而对照组为 6.31 +/- 2.41 和 3.00 +/- 1.97 毫米(2)(p<0.05)。牙骨质再生包括有或无功能定向牙周韧带的细胞/无细胞牙骨质。假手术对照组可见非特异性连接组织附着。对照组主要表现为编织骨和初级骨单位,而 rhGDF-5/β-TCP 部位则表现出明显的板层骨。接受 rhGDF-5/β-TCP 或β-TCP 的部位有一些残留的β-TCP 颗粒,显然正在进行生物降解,但这些部位之间没有明显差异。单独接受β-TCP 的部位通常可见残留的β-TCP 颗粒被隔离在结缔组织或纤维血管骨髓中。
rhGDF-5/β-TCP 具有更大的潜力支持牙周附着的再生。需要进行长期研究以确认再生组织的成熟过程无异常。